-+ 0.00%
-+ 0.00%
-+ 0.00%

AGOMAB THERAPEUTICS NV - NOV-ERA PHASE 2B STUDY EXPECTED TO ENROLL ABOUT 320 PATIENTS GLOBALLY

Reuters·10/13/2026 20:05:01

Please log in to view news